ARTICLE | Clinical News
FCX-007 regulatory update
October 5, 2015 7:00 AM UTC
Fibrocell said FDA requested an additional animal safety study in an IND for FCX-007 to treat recessive dystrophic epidermolysis bullosa (RDEB). FDA requested a toxicology-specific study in which FCX-...